(Q34370482)

1 August 2017

1 reference

title

Telmisartan: a review of its use in hypertension (English)

1 reference

1 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

M Sharpe

1

1 reference

1 August 2017

B Jarvis

series ordinal

2

1 reference

1 August 2017

K L Goa

series ordinal

3

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

61

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1501-1529

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161100-00009

1 August 2017

exact match

0 references

cites work

British Hypertension Society guidelines for hypertension management 1999: summary

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200161100-00009

Newly emerging pharmacologic differences in angiotensin II receptor blockers

21 January 2018

1 reference

12 December 2020

Cell biology of atherosclerosis

1 reference

12 December 2020

Ambulatory blood pressure monitoring to assess the comparative efficacy and duration of action of a novel new angiotensin II receptor blocker--telmisartan.

1 reference

12 December 2020

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

1 reference

12 December 2020

Angiotensin II receptor antagonists

1 reference

12 December 2020

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

1 reference

12 December 2020

The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.

1 reference

12 December 2020

Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade

1 reference

12 December 2020

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee

1 reference

12 December 2020

The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers

1 reference

12 December 2020

Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats

1 reference

12 December 2020

Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions

1 reference

12 December 2020

Dose response and safety of telmisartan in patients with mild to moderate hypertension

1 reference

12 December 2020

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Drug therapy: patient compliance.

1 reference

12 December 2020

Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers

1 reference

12 December 2020

A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring

1 reference

12 December 2020

Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients

1 reference

12 December 2020

Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

1 reference

12 December 2020

Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers

1 reference

12 December 2020

Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers

1 reference

12 December 2020

A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers

1 reference

12 December 2020

Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.

1 reference

12 December 2020

Diuretics vs alpha-blockers for treatment of hypertension: lessons from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

1 reference

12 December 2020

Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.

1 reference

12 December 2020

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study

1 reference

12 December 2020

Angiotensin II-receptor blockers: clinical relevance and therapeutic role

1 reference

12 December 2020

Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats

1 reference

12 December 2020

Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo

1 reference

12 December 2020

Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Intrinsically long-acting agents compared with long-acting chronoformulations.

1 reference

12 December 2020

ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management

1 reference

12 December 2020

Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i

1 reference

12 December 2020

Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists

1 reference

12 December 2020

Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension

1 reference

12 December 2020

Disposition and chemical stability of telmisartan 1-O-acylglucuronide

1 reference

12 December 2020

Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium.

1 reference

12 December 2020

Molecular biology of angiotensin II biosynthesis and receptors

1 reference

12 December 2020

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

1 reference

12 December 2020

Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers

1 reference

12 December 2020

Effects of telmisartan on renal excretory function in conscious dogs

1 reference

12 December 2020

Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension

1 reference

12 December 2020

The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group

1 reference

12 December 2020

Angiotensin II receptors in the rat lung are of the AII-1 subtype.

1 reference

12 December 2020

Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain

1 reference

12 December 2020

ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada

1 reference

12 December 2020

Effects on binding characteristics and renal function of the novel, non-peptide angiotensin II antagonist BIBR277 in the rat

1 reference

12 December 2020

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

1 reference

12 December 2020

Should new drugs be used without outcome data? Implications of Allhat and Elite II.

1 reference

12 December 2020

Effects of the AT1-selective angiotensin II antagonist, telmisartan, on hemodynamics and ventricular function after cardiopulmonary resuscitation in pigs

1 reference

12 December 2020

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

1 reference

12 December 2020

10.2165/00003495-200161100-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1031612184

0 references

1 reference